HAART and response to therapy improve quality of life (QOL) of African patients with advanced HIV-associated Kaposi’s sarcoma (HIV-KS): a prospective analysis of QOL in the KAART trial

Lignende værker

• The KAART Trial: a randomized controlled trial of HAART compared to the combination of HAART and chemotherapy in treatment-naïve patients with HIV-associated Kaposi sarcoma (HIV-KS) in KwaZulu-Natal (KZN), South Africa
  af: Aboobaker J, et al.
  Udgivet: (2010-10-01)
• Health-Related Quality of Life in Patients Treated With Antiretroviral Therapy Only Versus Chemotherapy and Antiretroviral Therapy for HIV-Associated Kaposi Sarcoma: A Randomized Control Trial
  af: Fahmida Shaik, et al.
  Udgivet: (2018-10-01)
• Early Changes in Health-Related Quality of Life as a Biomarker of Survival in African Patients with HIV-Associated Kaposi Sarcoma
  af: Fahmida Shaik, et al.
  Udgivet: (2024-10-01)
• Prognosis of patients with AIDS-associated Kaposi's sarcoma receiving antiretroviral therapy +/- chemotherapy in Kwazulu-Natal, South Africa: an analysis of 1-yr survival data from NCT00380770
  af: Skadden D, et al.
  Udgivet: (2009-06-01)
• Increasing incidence of Kaposi's sarcoma in black South Africans In Kwazulu-Natal, South Africa (1983 to 2006)
  af: Shaik F, et al.
  Udgivet: (2009-06-01)